Seçkin Bilgiç

Dr. Seçkin Bilgiç

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
CTCuneyt Tetikkurt
Cuneyt Tetikkurt
HYHalil Yanardag
Halil Yanardag
HSHaluk Burcak Sayman
Haluk Burcak Sayman
MBMuammer Bilir
Muammer Bilir
STSeza Tetikkurt
Seza Tetikkurt
SBSeyda Bilgin
Seyda Bilgin
Sarcoidosis is a chronic granulomatous disease of unknown etiology. The disease most commonly involves the lungs and the mediastinal lymph nodes while extrapulmonary organs such as the skin, eye, liver or spleen may also be comprised. Many imaging modalities have been used for the clinical evaluation of sarcoidosis patients but all have been found to have certain drawbacks for a reliable identification assessment due to the equivocal diagnostic results. This case series was designed to determine the clinical trenchancy of simultaneous 68Ga citrate PET/CT [Positron emission tomography with 68Ga citrate (68Ga citrate PET/CT)] and 18F-FDG PET/CT [Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose integrated with computed tomography (18F-FDG PET/CT)] imaging in sarcoidosis patients. The main goal of the study was to evaluate sarcoidosis with respect to disease activity and organ involvement. A total of eight sarcoidosis patients with a comorbid disease suspicion were included in the study. Conventional clinical parameters used for the diagnosis and the activity of sarcoidosis including CT [Computed tomography (CT)] were compared with the 68Ga-citrate PET/CT findings. Concurrent 18F-FDG PET/CT was performed to verify the granulomatous inflammation of sarcoidosis and to determine coexisting malignant or other inflammatory diseases. Our study results revealed that 68Ga citrate PET/CT imaging appears to be highly useful for the diagnosis, activity assessment and extrapulmonary organ involvement in sarcoidosis. Another crucial finding was the detection of extrapulmonary organ disease that are exceptionally involved, almost inaccessible by biopsy and that could not be otherwise displayed by other conventional imaging modalities. The third hallmark was the identification of a clinically asymptomatic and occult malignancy accompanying sarcoidosis that would not be revealed in any way if synchronous 18FDG PET/CT had not been performed. Simultaneous application of 68Ga citrate and 18FDG PET/CT may provide extremely useful data for the clinical evaluation of sarcoidosis patients in terms of the primary disease diagnosis, activity state, extrapulmonary organ involvement unachievable for biopsy and the clinically occult malignant disorders.

14 October 2024 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
RMRasimcan Meral
Rasimcan Meral
SSSait SAGER
Sait SAGER
KSKerim Sönmezoğlu
Kerim Sönmezoğlu
Papillary thyroid cancer (PTC) is the most common thyroid malignancy, characterized by its slow progression and favorable prognosis. This study re-evaluates the efficacy of radioactive iodine (RAI) therapy versus no RAI in low-risk PTC patients following total thyroidectomy. A retrospective analysis was conducted on 588 patients treated between 2010 and 2016 at a major tertiary center in Turkey. Patients were divided into two cohorts: those receiving total thyroidectomy (TT) with high-dose RAI (100 mCi) and those receiving TT alone. A matched cohort of 138 patients per group was analyzed to minimize bias. Follow-up data indicated that at 24 months, the RAI group demonstrated a higher percentage of excellent treatment responses (86%) compared to the non-RAI group (74%). Long-term follow-up showed that 99.3% of the RAI group achieved no evidence of disease (NED), versus 90.6% in the non-RAI group. Recurrence rates were significantly lower in the RAI group (1%) compared to the non-RAI group (5.8% with a > 2.0 ng/ml cut-off for biological events). In summary, the findings from this study underscore the efficacy of RAI therapy in reducing recurrence rates and enhancing long-term disease control in low-risk papillary thyroid cancer patients. While total thyroidectomy alone is effective, the addition of RAI therapy provides a marked improvement in treatment responses and reduces the risk of disease recurrence. This indicates that personalized treatment plans incorporating RAI may offer significant advantages in managing low-risk PTC.

27 October 2021 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
HSHaluk Burcak Sayman
Haluk Burcak Sayman
FGFatih Gulsen
Fatih Gulsen
SSSait Sager
Sait Sager
EAElife Akgun
Elife Akgun
NYNami Yeyin
Nami Yeyin
OAOmer Aras
Omer Aras

6 September 2024 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
ETEbru Tatcı
Ebru Tatcı
ÖÖÖzlem Özmen
Özlem Özmen
DKDerya Kızılgöz
Derya Kızılgöz
FDFunda Demirağ
Funda Demirağ
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
Objectives: The purpose of this study was to investigate whether18F-fluorodeoxyglucose 18 F-fluorodeoxyglucose (18F-FDG) 18 F-FDG) positron emission tomography/computed tomography (PET/CT) parameters have a role in differentiating invasive mucinous lung adenocarcinoma (IMA) from lepidic predominant lung adenocarcinoma (LPA). Additionally, we compared the18F-FDG-PET/CT 18 F-FDG-PET/CT features between survivors and non-survivors. Methods: Tumors were divided into 2 groups according to CT appearance: Group 1: nodular-type tumor; group 2: mass- or pneumonic-type tumor. Unilateral and bilateral multifocal diseases were detected. Clinicopathological characteristics and PET/CT findings were compared between IMAs and LPAs, as well as between survivors and non-survivors. Results: We included 43 patients with IMA and 14 with LPA. Tumor size (p=0.003), incidence of mass/pneumonic type (p=0.011), and bilateral lung involvement (p=0.049) were higher in IMAs than in LPAs. IMAs had more advanced T, M, and Tumor, Node, and Metastasis stages than in LPAs (p=0.048, p=0.049, and p=0.022, respectively). There was no statistically significant difference in maximum standardized uptake value (SUVmax) max ) between the IMA and LPA (p=0.078). The SUV was significantly lower in the nodular group than in the mass/pneumonic-type group (p=0.0001). A total of 11 patients died, of whom SUVmax max values were significantly higher in these patients (p=0.031). Male gender (p=0.0001), rate of stage III-IV (p=0.0001), T3-T4 (p=0.021), M1 stages (p=0.0001), multifocality (p=0.0001), and bilateral lung involvement (p=0.0001) were higher in non-survivor. Conclusions: Although CT images were useful for the differential diagnosis of LPAs and IMAs, SUVmax max was not helpful for differentiation of these 2 groups. However, both18F-FDG 18 F-FDG uptake and CT findings may play an important role in predicting prognosis in these patients.

1 April 2021 in World Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
HSHaluk Burçak Sayman
Haluk Burçak Sayman
MSMuhammet Sait Sager
Muhammet Sait Sager
KSKerim Sonmezoglu
Kerim Sonmezoglu
Prostate-specific membrane antigen (PSMA) is a glycosylated type-II transmembrane protein highly expressed in individual tumor cells. Lesions with PSMA expression in the liver are commonly reported as prostate cancer metastasis or hepatocellular cancer previously. This is the first case reported as hepatic focal nodular hyperplasia, mimicking hepatocellular carcinoma with imaging features. This patient, having a lesion that has been enlarged from 2.0 cm to 2.5 cm in 3 months, was referred to our department for restaging by gallium-68 PSMA (68Ga-PSMA) positron emission tomography/computed tomography (PET/CT). The CT scan showed a focal segment VI hypodensity, which was significantly PSMA-avid. Consequently, its biopsy resulted as focal nodular hyperplasia in liver. His follow-up 68Ga-PSMA PET/CT ultimately revealed a mass lesion of 8 cm of axial diameter.

1 February 2021 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
SSSait SAGER
Sait SAGER
Seçkin BilgiçSeçkin Bilgiç
Seçkin Bilgiç
LULebriz Uslu-Besli
Lebriz Uslu-Besli
SASertaç Asa
Sertaç Asa
SŞsafiye güneş şentürk
safiye güneş şentürk
KSKerim Sönmezoğlu
Kerim Sönmezoğlu
Vasculitis is a multisystem disease characterized by inflammation with infiltration of leukocytes into the blood vessels. Giant cell arteritis (GCA) is the most common form of vasculitis that mostly affects mediumand large-sized arteries. (18)Fluorine-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) is increasingly used to diagnose inflammation of large arteries in GCA. Galium-68 prostate-specific membrane antigen (PSMA) PET/CT has a vital role in the assessment of patients with prostate cancer for recurrence and metastasis of the disease. Various benign and non-prostate malignant conditions may give rise to increased PSMA uptake. Herein, we demonstrate that PSMA uptake can be seen in GCA.